La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Human Health Holdings Bilan de santé

Santé financière contrôle des critères 4/6

Human Health Holdings possède un total de capitaux propres de HK$764.6M et une dette totale de HK$33.3M, ce qui porte son ratio d'endettement à 4.4%. Son actif total et son passif total sont HK$1.1B et de HK$307.4M.

Informations clés

4.4%

Ratio d'endettement

HK$33.28m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	HK$484.41m
Fonds propres	HK$764.57m
Total du passif	HK$307.39m
Total des actifs	HK$1.07b

Mises à jour récentes de la santé financière

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

May 31

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Feb 15

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Dec 25

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 1419 ( HK$612.7M ) dépassent ses passifs à court terme ( HK$220.0M ).

Passif à long terme: Les actifs à court terme de 1419 ( HK$612.7M ) dépassent ses passifs à long terme ( HK$87.4M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 1419 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 1419 est passé de 0% à 4.4% au cours des 5 dernières années.

Couverture de la dette: La dette de 1419 est bien couverte par le flux de trésorerie opérationnel ( 517.1% ).

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 1419 sur sa dette sont bien couverts par l'EBIT.

Human Health Holdings Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines